PhRMA names former House Majority Leader Eric Cantor as new CEO

PhRMA, the U.S. pharmaceutical lobby, has appointed former Republican House Majority Leader Eric Cantor as its next CEO. The move signals a strategic pivot toward political influence as the industry faces drug pricing pressures and legislative scrutiny. Cantor's political connections may bolster PhRMA's advocacy but also draw criticism given his lobbying background.